Profile picture

Mr Guiquan Zhou

Xinqiao Hospital, Army Medical University, Chongqing (China)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Empagliflozin attenuates adverse outcomes of acute ischemic heart failure by targeting NLRP3/IL1β mediated macrophage polarization and inflammatory response
Presentation
Empagliflozin attenuates adverse outcomes of acute ischemic heart failure by targeting NLRP3/IL1β mediated macrophage polarization and inflammatory response
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources